학술논문

The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma
Document Type
Article
Source
In Modern Pathology February 2021 34(2):327-335
Subject
Language
ISSN
0893-3952